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IntroductionObesity has reached pandemic proportions; according to the World Health Organization (WHO), over 500 million adults (10-14% of world population) were obese in 2008, and this number keeps increasing [1-3]. As of 2014, greater than 1/3 of US adults 
would be classified as obese [4]. There is a strong association between hypertension and obesity, but the mechanism(s) by which obesity predisposes to hypertension has (have) not clearly 
been defined [5].
The body mass index (BMI) has been used as a way to assess obesity, but unfortunately it does not distinguish between adipose 
and muscle tissues. Clearly, subjects can have BMI values that would classify them as “obese” while their anthropomorphic measurements would register low percentages of body fat. As 
creatinine excretion is believed to be a reflection of muscle mass 
[6], we chose to look at the subjects of the Modification of Diet in 
Renal Diseases where such data were readily available [7].
MethodsA retrospective study was performed using data acquired in 
the “Modification of Diet in Renal Diseases” or MDRD study [7]. 
Results from this study have been reported elsewhere [7-11]. 
These data containing 25,903 records were imported into R 
Studio and simplified into 840 unique patient records. From these data, linear regression analysis was performed with the quality 
of the fit reported as an adjusted R2. Regression figures were 
made with the GGPLOT2 and SCATTER3D packages. Once we had 
evidence supporting the use of the ratio of body mass index (BMI) 
to urinary creatinine excretion rate (UCRV), we sorted patients 
based on this BMI/UCRV value and compared the different 
quartiles using one way ANOVA. Group means were individually compared using the t-test employing Holm’s correction for 
multiple comparisons. Significance values are reported at the 
p = NS, p<0.05 and p<0.01 levels. These data were graphically shown as “pirate” plots showing the actual data as scatter points, the distribution as a bean shape (evoking a pirate’s beard) and 
the mean +/- 95% confidence intervals shown as the thickness of the top of the bar (https://www.r-bloggers.com/the-pirate-plot-2-0-the-rdi-plotting-choice-of-r-pirates/). Creating these graphs 
required the loading of the DEVTOOLS and YARRR packages. 
Once base figures were produced in R Studio, they were exported 
as jpeg files, and final annotation was performed in Microsoft PowerPoint.
Results
We observed that there were significant correlations between 
BMI and systolic, and pulse pressures although the correlation with diastolic blood pressure did not achieve statistical 
significance (Figure 1). Urinary creatinine excretion rate (UCRV) 
did not correlate significantly with systolic blood pressure but did 
correlate significantly with diastolic and pulse pressures (Figure 
2). When we combined BMI and UCRV, the plane of prediction correlated well with the pulse pressure, achieving an adjusted R2 
value of 0.06263, p<0.01 (Figure 3).
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AbstractObesity is a known risk factor for hypertension, but the mechanisms by which this 
occurs are still unclear. As the body mass index (BMI) is frequently used to define 
obesity, but the BMI does not distinguish between adipose and other tissues, we 
sought to develop another index of obesity. We decided to look at the ratio of BMI 
to urinary creatinine excretion as the latter measurement is believed to be an 
index of muscle mass. We used data from the modification of diet in renal disease 
(MDRD) study as urinary creatinine collections and blood pressure measurements 
were readily available in this data set. The UCRV correlated well with lean body mass determined by anthropomorphic measurements available on this data set. 
We found that the BMI/UCRV ratio correlated with either percent body fat (PBF) 
or total body fat calculated as the product of PBF and weight. We also found that 
the BMI/UCRV ratio correlated significantly with systolic, diastolic and especially 
pulse pressure in this population. These data suggest that adipocyte mass has a relationship to blood pressure in subjects with renal disease. Should these 
data be confirmed in other populations, the BMI/UCRV ratio may prove to be a useful measurement in patients at risk for hypertension and other cardiovascular diseases.
Keywords: Hypertension; Blood pressure; CKD; Correlation; Cardiovascular disease
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With these observations in mind, we constructed the ratio 
of BMI/UCRV. UCRV correlated well with the lean body mass calculated as the product of (100-percent body fat)/100 and body 
weight (in kg) (adjusted R2 = 0.56, p<0.01). This BMI/UCRV ratio correlated quite well with both percent body fat determination 
determined by anthropromorphic measurements (Figure 4). The 
BMI/UCRV correlated significantly with the systolic, diastolic and pulse pressures, the latter correlation having an adjusted 
R2 (adjusted R2= 0.05802, p<0.01) approaching that of BMI 
and UCRV combined in a multiple regression analysis (Figure 
5). The correlation of the BMI/UCRV ratio to pulse pressure was considerably better than that of percent body fat to pulse pressure which achieved an adjusted R2 of only 0.031115 (p<0.01).
To better understand the predictive capability of the ratio 
of BMI/UCRV, we divided our patients into quartiles defined 
by this measurement. As expected the data were distinct and 
significantly different (all p<0.01). Again, as expected from the regression analysis, the percent body fat of the patients separated 
into quartiles were also significantly different (all p<0.01). The 
components of the ratio, BMI and UCRV also differed significantly 
in the quartiles (all p<0.01). These data are summarized in Figure 
6. When we examined systolic, diastolic and pulse pressures, we saw the segmentation of the population into quartiles based on 
the BMI/UCRV ratio showed varying degrees of difference in these measurements. As we might have inferred from the regression analysis, the separation showed the greatest difference in pulse 
pressures (Figure 7).
Figure 1: Correlation of body mass index (BMI) with systolic (Panel A), diastolic (Panel and pulse pressure (Panel C). Raw data extracted from baseline visit of 840 unique patients show as scatter plots. Linear regression shown (red line) with estimate error shown as grey bands surrounding regression line. Panel A: Adjusted R2 = 0.021, p < 0.01. Panel B: Adjusted R2 0.003, p = NS. Panel C: Adjusted R2 = 0.014, p < 0.01.
Figure 2: Correlation of urinary creatinine excretion rate (UCRV) with systolic (Panel A), diastolic (Panel B) and pulse pressure (Panel C). Panel A: Adjusted R2 = 0.002, p = NS. Panel B: Adjusted R2 0.033, p < 0.01. Panel C: Adjusted R2 = 0.024, p < 0.01.
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Figure 3: 3D scatterplot showing BMI and UCRV together as predictors of pulse pressure (PP). Plane of prediction shown in red. Adjusted R2 for plane is 0.063, p < 0.01.
Figure 4: Correlation between ratio of BMI to UCRV (BMI/UCRV Ratio) to body fat percentage determined by anthropromorphic measurements. Adjusted R2 = 0.334, p < 0.01.
Discussion
The link between obesity and hypertension is well established and profound [12]. However, there is still considerable uncertainty 
as to the molecular mechanisms involved. Most of the putative mechanisms which have been proposed and studied involve adipose tissue itself, either through mass, hormonal or cytokine effects producing renal salt sensitivity and/or hypertension itself. 
Based on these observations, we thought it would be reasonable to 
examine whether we could develop a biochemical measurement 
of adiposity and examine its performance.
Urinary creatinine excretion is believed to be determined largely by muscle mass as creatinine is produced by the non-enzymatic degradation of creatine, and creatine is present in a large and predictable concentration in skeletal muscle [13]. 
Unfortunately, creatinine excretion rates require the collection of timed urine specimens which are not available in most clinical 
studies. One such study, in addition to the MDRD study examined 
in the paper, is the famous Intersalt study where such urine 
collections as well as BMI and blood pressure measurements were made on normal volunteers at 52 centers from across the world. We recently completed a study of those data which was somewhat 
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limited in that individual subject data was not available. When one uses the center mean data, we found a confusing and disturbing 
negative correlation of the BMI/UCRV to systolic, diastolic and 
pulse pressures [14]. As these data were absolutely contradictory 
to our expectations, we sought a patient population where we could further test our hypothesis with individual patient data.
Figure 5: Correlation of BMI/UCRV ratio with systolic (Panel A), diastolic (Panel B) and pulse pressure (Panel C). Panel A: Adjusted R2 = 0.018, p < 
0.01. Panel B: Adjusted R2 0.023, p < 0.01. Panel C: Adjusted R2 = 0.058, p < 0.01.
Figure 6: Pirate plots comparing quartiles of patients created based on the BMI/UCRV ratio. Panel A shows the BMI/UCRV ratio data. Panel B shows 
percent body fat. Panel C shows BMI and Panel D shows UCRV. Groups compared by ANOVA with group means compared to each other with a t-test employing Holm’s correction for multiple comparisons.
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Figure 7: Pirate plots comparing quartiles of patients created based on the BMI/UCRV ratio. Panel A shows systolic blood pressure (SBP), Panel B 
shows diastolic blood pressure (DBP) and Panel C shows pulse pressure (PP). Groups compared by ANOVA with group means compared to each other with a t-test employing Holm’s correction for multiple comparisons.
The MDRD study is famous for yielding clinical estimates of 
glomerular filtration rate, but it should be emphasized that it was developed to test whether dietary protein restriction would 
ameliorate the progression of renal failure. This study has been 
reviewed extensively elsewhere, but for the purpose of our interest, we had a group of patients, albeit those with some degree of chronic kidney disease, in which we could compare the baseline 
values of BMI, urinary creatinine excretion to systolic, diastolic and pulse pressures. As shown in this paper, our ratio correlated with another measurements of adiposity performed on these subjects and predicted the systolic, diastolic and especially pulse 
pressure in this population to a significant degree.
This study highlights the importance of human body 
components in CV risk profile rather than simply the body mass. 
It also adds more weight to body fat content as being the driver of this link. We have shown, among others, the importance of 
inflammation evident by inflammatory biomarkers profile and adipokines in obese rodents and humans suggesting the pivotal role of adipocytes dysfunction, a hallmark and consequence of obesity, in vascular dysfunction and metabolic syndrome [15-
20]. Moreover, abnormal renal sodium handling, salt sensitivity and sympathetic over-activity have also been shown to link hypertension and obesity [21,22].
Our study has limitations. First and foremost, the patients in 
the MDRD study had variable degrees of renal dysfunction. It is, 
in fact, possible that our findings are not extendable to a normal 
population. Second, anti-hypertensives used by some of the study population could have altered the relationship between adiposity and blood pressure. We strongly suspect that the use of such medications to achieve varying degrees of compliance with 
the standards of the 1980s created some degree of confounding 
results. Third, we found that the BMI/UCRV ratio correlated best with pulse pressure rather than systolic or diastolic pressure. Although the pulse pressure has been shown to be a better 
predictor of CV risk in subjects older than 60 years [23], we found 
this relationship significant throughout the MDRD population. 
This can point to the relevance of perfusion pressure in subjects 
with CKD regardless of their age. Finally, it is important to stress that our results show correlation rather than causation and it is required to have different type of study design to determine whether and how the adipocyte mass can affect blood pressure and whether our ratio can serve as a reasonable surrogate.
In this population at risk for CVD, adipose mass assessed by the 
BMI/UCRV ratio appears to correlate with blood pressure and, in 
particular, pulse pressure. This ratio needs further to be examined and validated in other populations as well as in interventional studies where some element of causation can be dissected.
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